Not investment advice. Educational platform. See Disclaimer.
NASDAQ: AARD
Aardvark Therapeutics, Inc. Common Stock
Healthcare | Biotechnology
Market prices for AARD are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
EPS (TTM)$-3.21
Aardvark Therapeutics, Inc. Common Stock (NASDAQ: AARD) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 20:48 UTC.
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
2026-06-12Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2026-02-12Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
What does Aardvark Therapeutics, Inc. Common Stock do?
Aardvark Therapeutics, Inc. Common Stock is a biotechnology company, listed on NASDAQ as AARD.
When did AARD last file with the SEC?
Aardvark Therapeutics, Inc. Common Stock's most recent SEC filing on record is a DEF 14A filed 2026-07-10. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 20:48 UTC. This page is also available as JSON at /api/data?ticker=AARD and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for AARD and 5,000+ tickers.